Abiopharma

New Form 144 - AGIOS PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001900772-25-000003 Size: 4 KB

New Form 4 - Keros Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001104659-25-062092 Size: 21 KB

New Form 4 - Twist Bioscience Corp Filed: 2025-06-24 AccNo: 0001214659-25-009547 Size: 5 KB

New Form 4 - Twist Bioscience Corp Filed: 2025-06-24 AccNo: 0001214659-25-009548 Size: 5 KB

BioVie Inc. - BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & RelatedDisorders® Congress

Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium

Spider-Man: Beyond the Spider-Verse – Everything We Know So Far

11-K (Annual Report of Employee Stock Plans) SEC Filing

New Form DEFA14A - Rein Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001193125-25-145714 Size: 16 KB

New Form 8-K - MIRA PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001641172-25-016285 Size: 209 KB Item 8.01: Other Events

New Form 144 - AGIOS PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001900772-25-000002 Size: 4 KB

Verastem Oncology Announces First Patient Dosed with VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in a U.S. Phase 1/2a Trial in KRAS G12D Advanced Solid Tumors

New Form 8-K - KINETA, INC./DE Filed: 2025-06-24 AccNo: 0000950170-25-089443 Size: 271 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 11-K - EXACT SCIENCES CORP Filed: 2025-06-24 AccNo: 0001124140-25-000051 Size: 216 KB

New Form 8-K - Rein Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001193125-25-145711 Size: 136 KB Item 8.01: Other Events